KAILUA-KONA, Hawaii--(BUSINESS WIRE)--Responding to questions related to news reports about adulterated ingredients and products entering the world market for human consumption, Cyanotech (Nasdaq:CYAN), the world's leading producer of microalgae products for human consumption, issued a statement about the quality and integrity of its products and processes. Cyanotech produces and markets BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica® in more than 40 countries worldwide.

"We believe it is important for our customers to clearly understand how pure our products are — grown in the pristine environment of Kona, Hawaii — and how safe they are for human use," said Gerald R. Cysewski, PhD, Cyanotech's President and CEO. "An example of our outstanding safety and quality is our Hawaiian Spirulina, which has GRAS status (Generally Recognized As Safe for use in all food, beverage and supplement applications) by the FDA. Spirulina is produced in many other countries, but none of them have attained the safety and quality standards to attain GRAS status."

"Cyanotech strives to produce the highest purity, most healthful products possible. No herbicides or pesticides are used anywhere in our microalgae cultivation and processing facility. Only the highest purity nutrients sourced from manufacturers in either the US or Canada are used in our microalgae culture system. In addition, all culture nutrients are tested upon arrival at Cyanotech prior to their use. Materials used for the manufacture of our final product forms of tablets, oleoresin, beadlets, and softgel capsules undergo similar scrutiny. All material is sourced from manufacturers in the US or Canada, are non-GMO (non-genetically modified organism), are pharmaceutical grade, and undergo testing prior to their use."